PMV Pharma Granted FDA Fast Track Designation of PC14586 for the Treatment of Advanced Cancer Patients that have Tumors with a p53 Y220C Mutation
October 13, 2020 08:00 ET
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Oct. 13, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., (Nasdaq: PMVP) a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic...
PMV Pharma Announces Closing of $243.5 Million Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
September 29, 2020 16:05 ET
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Sept. 29, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies...
PMV Pharma Announces Pricing of Initial Public Offering
September 24, 2020 20:06 ET
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Sept. 24, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies...
PMV Pharma Appoints Laurie Stelzer to the Board of Directors and Robert Ticktin as General Counsel
September 08, 2020 08:00 ET
|
PMV Pharmaceuticals, Inc.
CRANBURY, N. J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies...
PMV Pharma Closes $70 Million in Series D Financing
August 03, 2020 08:00 ET
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies...
PMV Pharma Appoints Leila Alland, M.D., as Chief Medical Officer
December 11, 2019 08:00 ET
|
PMV Pharmaceuticals, Inc.
CRANBURY, N.J., Dec. 11, 2019 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, today...